CD274 and cancer: TBMS-1 selectively binds mTOR kinase and suppresses mTORC1 activation to dysregulate PD-1/PD-L1 interactions and improve T cell cytotoxicity towards cancer cells by suppressing PD-L1 (Liu et al., 2021).